Increased dosage of Runx1/AML1 acts as a positive modulator of myeloid leukemogenesis in BXH2 mice

10.1038/sj.onc.1208675

Saved in:

Bibliographic Details
Main Authors:	Yanagida, M., Osato, M., Yamashita, N., Jacob, B., Cao, X., Ito, Y., Liqun, H., Wu, F., Shigesada, K., Nakamura, T., Yokomizo, T., Takahashi, S., Yamamoto, M.
Other Authors:	NATIONAL UNIVERSITY MEDICAL INSTITUTES
Format:	Article
Published:	2011
Subjects:	CBF Down syndrome GATA-1 Megakaryoblastic leukemia Runx
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/29050
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-29050
record_format	dspace
spelling	sg-nus-scholar.10635-290502023-10-30T08:29:40Z Increased dosage of Runx1/AML1 acts as a positive modulator of myeloid leukemogenesis in BXH2 mice Yanagida, M. Osato, M. Yamashita, N. Jacob, B. Cao, X. Ito, Y. Liqun, H. Wu, F. Shigesada, K. Nakamura, T. Yokomizo, T. Takahashi, S. Yamamoto, M. NATIONAL UNIVERSITY MEDICAL INSTITUTES MEDICINE CBF Down syndrome GATA-1 Megakaryoblastic leukemia Runx 10.1038/sj.onc.1208675 Oncogene 24 28 4477-4485 ONCNE 2011-11-29T09:23:37Z 2011-11-29T09:23:37Z 2005 Article Yanagida, M., Osato, M., Yamashita, N., Jacob, B., Cao, X., Ito, Y., Liqun, H., Wu, F., Shigesada, K., Nakamura, T., Yokomizo, T., Takahashi, S., Yamamoto, M. (2005). Increased dosage of Runx1/AML1 acts as a positive modulator of myeloid leukemogenesis in BXH2 mice. Oncogene 24 (28) : 4477-4485. ScholarBank@NUS Repository. https://doi.org/10.1038/sj.onc.1208675 09509232 http://scholarbank.nus.edu.sg/handle/10635/29050 000230157100001 Scopus
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	CBF Down syndrome GATA-1 Megakaryoblastic leukemia Runx
spellingShingle	CBF Down syndrome GATA-1 Megakaryoblastic leukemia Runx Yanagida, M. Osato, M. Yamashita, N. Jacob, B. Cao, X. Ito, Y. Liqun, H. Wu, F. Shigesada, K. Nakamura, T. Yokomizo, T. Takahashi, S. Yamamoto, M. Increased dosage of Runx1/AML1 acts as a positive modulator of myeloid leukemogenesis in BXH2 mice
description	10.1038/sj.onc.1208675
author2	NATIONAL UNIVERSITY MEDICAL INSTITUTES
author_facet	NATIONAL UNIVERSITY MEDICAL INSTITUTES Yanagida, M. Osato, M. Yamashita, N. Jacob, B. Cao, X. Ito, Y. Liqun, H. Wu, F. Shigesada, K. Nakamura, T. Yokomizo, T. Takahashi, S. Yamamoto, M.
format	Article
author	Yanagida, M. Osato, M. Yamashita, N. Jacob, B. Cao, X. Ito, Y. Liqun, H. Wu, F. Shigesada, K. Nakamura, T. Yokomizo, T. Takahashi, S. Yamamoto, M.
author_sort	Yanagida, M.
title	Increased dosage of Runx1/AML1 acts as a positive modulator of myeloid leukemogenesis in BXH2 mice
title_short	Increased dosage of Runx1/AML1 acts as a positive modulator of myeloid leukemogenesis in BXH2 mice
title_full	Increased dosage of Runx1/AML1 acts as a positive modulator of myeloid leukemogenesis in BXH2 mice
title_fullStr	Increased dosage of Runx1/AML1 acts as a positive modulator of myeloid leukemogenesis in BXH2 mice
title_full_unstemmed	Increased dosage of Runx1/AML1 acts as a positive modulator of myeloid leukemogenesis in BXH2 mice
title_sort	increased dosage of runx1/aml1 acts as a positive modulator of myeloid leukemogenesis in bxh2 mice
publishDate	2011
url	http://scholarbank.nus.edu.sg/handle/10635/29050
_version_	1781410685231562752

Increased dosage of Runx1/AML1 acts as a positive modulator of myeloid leukemogenesis in BXH2 mice

Similar Items